Our data demonstrated dual benefits of transplanting SDF-1α-iPS-NPCs into the injury including contributing exogenous cells that could differentiate into neurons and also enhancing endogenous regeneration after ischemic stroke. This evidence concerns the gene CXCL12 and ischemic stroke.